<DOC>
	<DOCNO>NCT00107601</DOCNO>
	<brief_summary>Glucontrol prospective , randomize , control , multi-centric study . The present study compare effect two regimen insulin therapy , respectively titrate achieve blood sugar level 4.4 6.1 mmol/l ( 80 110 mg/dl , respectively ) 7.8 10.0 mmol/l ( 140 180 mg/dl , respectively ) . This project aim define whether tight glucose control insulin improves vital outcome mixed population critically ill patient ( around 3000 patient ) . Secondary outcome variable include in-hospital 28-day mortality , lengths stay Intensive Care Unit ( ICU ) hospital , length ICU stay without life-support therapy , number clinical sign episodes hypoglycemia , rate infection organ failure , number red-cell transfusion .</brief_summary>
	<brief_title>Glucontrol Study : Comparing Effects Two Glucose Control Regimens Insulin Intensive Care Unit Patients</brief_title>
	<detailed_description>Hyperglycemia frequently occur critical illness commonly implicate development potentially lethal infectious , vascular metabolic complication . We hypothesize control glycemia insulin improve vital outcome rate complication heterogeneous population critically ill patient . This hypothesis support finding recent trial perform one surgical intensive care unit , demonstrate significant improvement vital outcome several index morbidity patient randomize tight control glycemia . However , finding hardly extrapolate condition , include different type pathology management . The present prospective , randomize , control multicentric study , compare effect two regimen insulin therapy , respectively titrate achieve blood sugar level 4.4 6.1 mmol/l ( 80 110 mg/dl , respectively ) 7.8 10.0 mmol/l ( 140 180 mg/dl , respectively ) power detect 4 % decrease absolute intensive care unit ( ICU ) mortality . Secondary outcome variable include in-hospital 28-day mortality , lengths stay ICU hospital , length ICU stay without life-support therapy , number clinical sign episodes hypoglycemia , rate infection organ failure , number red-cell transfusion .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>All adult ( old 18 year old admission ) patient admit Intensive Care Unit whatever reason Absence inform consent ( approved local ethical committee ) . Life expectancy low 24 hour , estimate upon admission . Therapeutic limitation upon admission ICU Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>Glucose</keyword>
	<keyword>Glucose Control</keyword>
	<keyword>Insulin</keyword>
	<keyword>Insulin therapy</keyword>
	<keyword>Critically ill</keyword>
	<keyword>Intensive Care</keyword>
</DOC>